Phase II Trial of BrECADD in HIV-Positive Patients With Advanced-Stage Classical Hodgkin Lymphoma
NCT06919679
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Hodgkin Lymphoma (Category)
Interventions
DRUG:
BrECADD
Sponsor
University of Cologne